12:00 AM
Jan 23, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

IFX-1: Phase I data

A double-blind, placebo-controlled, dose-escalation, German Phase I trial in 26 healthy male volunteers showed that single ascending-doses of...

Read the full 66 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >